Skip to Content

Lazard US Equity Concentrated Open LEVOX

Medalist Rating as of | See Lazard Investment Hub
  • NAV / 1-Day Return 8.47  /  −0.47 %
  • Total Assets 140.9 Mil
  • Adj. Expense Ratio
    1.040%
  • Expense Ratio 1.040%
  • Distribution Fee Level Above Average
  • Share Class Type No Load
  • Category Large Blend
  • Investment Style Large Blend
  • Min. Initial Investment 2,500
  • Status Open
  • TTM Yield 0.82%
  • Turnover 81%

USD | NAV as of Apr 18, 2024 | 1-Day Return as of Apr 18, 2024, 10:16 PM GMT+0

Morningstar’s Analysis LEVOX

Will LEVOX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Lead Manager of Lazard US Equity Concentrated Steps Down; Ratings Under Review

null David Carey

David Carey

Analyst Note

Lazard announced that Lazard US Equity Concentrated lead manager Chris Blake has stepped down from the strategy but will remain at the firm through June 2024. Sean Gallagher will replace him as lead manager, and comanagers Martin Flood and Jay Levy will support him. The strategy’s Morningstar Medalist Rating is Under Review. Blake’s departure comes amid a tough stretch for the strategy. Blake had managed the strategy in separate accounts since 2003 and built up a decent track record before he took over the mutual fund version at the end of May 2012. Since then, performance has been underwhelming. Through March 2024, the institutional shares’ 12.0% annualized return trailed 88% of its large-blend Morningstar Category peers. Poor stock selection weighed on performance over the period, particularly in crucial areas such as technology and healthcare. To make matters worse, the mutual fund shed about $1.1 billion of assets in 2023, which brought its total assets down to around $140 million as of March 2024. Gallagher’s roughly 20 years of industry experience is a plus, but he is relatively new to the firm and it's unclear what changes he will implement when he takes over. After joining Lazard in December 2023, Gallagher became manager of Lazard US Small Cap Equity Select LZSCX, which he will continue managing in addition to this strategy. It’s expected that Gallagher will implement a different approach from Blake; the portfolio is expected to change as well.

Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings LEVOX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 62.6
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Laboratory Corp of America Holdings

11.31 16.2 Mil
Healthcare

Alphabet Inc Class A

8.06 11.5 Mil
Communication Services

S&P Global Inc

6.83 9.8 Mil
Financial Services

Oracle Corp

6.21 8.9 Mil
Technology

Analog Devices Inc

5.46 7.8 Mil
Technology

Fidelity National Information Services Inc

5.26 7.5 Mil
Technology

Visa Inc Class A

4.98 7.1 Mil
Financial Services

Otis Worldwide Corp Ordinary Shares

4.93 7.0 Mil
Industrials

Public Storage

4.83 6.9 Mil
Real Estate

Crown Castle Inc

4.74 6.8 Mil
Real Estate